CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib

Saved in:
Bibliographic Details
Published inValue in health Vol. 27; no. 6; p. S20
Main Authors Desai, J., Wagner, AJ, Carrasco, Garcia I., Cesari, M., Gordon, M., Lin, CC, Papai, Z., Ryan, CW, Tap, WD, Trent, JC, Gelderblom, H., Grimison, P., López, Pousa A., Tine, Van, Dai, D., Rubinacci, M., Tecson, K., Wooddell, M., Stacchiotti, S.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2024
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2024.03.111